Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration.
Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration.
复制标题
DOI:
10.1038/nature16460
复制
发表时间:
2015-12-24
期刊:
影响因子:
64.8
通讯作者:
Hanash AM
中科院分区:
文献类型:
--
作者:
Lindemans CA;Calafiore M;Mertelsmann AM;O'Connor MH;Dudakov JA;Jenq RR;Velardi E;Young LF;Smith OM;Lawrence G;Ivanov JA;Fu YY;Takashima S;Hua G;Martin ML;O'Rourke KP;Lo YH;Mokry M;Romera-Hernandez M;Cupedo T;Dow L;Nieuwenhuis EE;Shroyer NF;Liu C;Kolesnick R;van den Brink MRM;Hanash AM
Epithelial regeneration is critical for barrier maintenance and organ function after intestinal injury. The intestinal stem cell (ISC) niche provides Wnt, Notch, and epidermal growth factor (EGF) signals supporting Lgr5+ crypt base columnar ISCs for normal epithelial maintenance. However, little is known about the regulation of the ISC compartment after tissue damage. Utilizing ex vivo organoid cultures, we provide evidence that innate lymphoid cells (ILCs), potent producers of Interleukin-22 (IL-22) after intestinal injury, increased the growth of murine small intestine (SI) organoids in an IL-22-dependent fashion. Recombinant IL-22 directly targeted ISCs, augmenting the growth of both murine and human intestinal organoids, increasing proliferation, and promoting ISC expansion. IL-22 induced Stat3 phosphorylation in Lgr5+ ISCs, and Stat3 was critical for both organoid formation and IL-22-mediated regeneration. Treatment with IL-22 in vivo after murine allogeneic bone marrow transplantation (BMT) enhanced recovery of ISCs, increased epithelial regeneration, and reduced intestinal pathology and mortality from graft vs. host disease (GVHD). Atoh1-deficient organoid culture demonstrated that IL-22 induced epithelial regeneration independent of the Paneth cell niche. Our findings reveal a fundamental mechanism by which the immune system is able to support intestinal epithelium, activating ISCs to promote regeneration.